En español



Quick Links

AIDS Research Program (ARP)

What We Do:

NIDA AIDS research program logo

Established in February 2005, NIDA's AIDS Research Program (ARP) supports the development, planning, and coordination of high priority research on HIV/AIDS and drug abuse within NIDA as well as across NIH Institutes and other DHHS agencies. ARP ensures that there an integrated vision and strategy to guide HIV/AIDS research throughout NIDA that is responsive to the evolving nature of HIV/AIDS disease among drug users in the U.S. and internationally.


NIH OAR Seeks Input on the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

The NIH OAR is soliciting feedback from its stakeholder communities on the current NIH HIV research priorities and funding guidelines through a Request for Information (RFI). The public comment period for the RFI closes on April 13, 2019, and all responses will be reviewed and considered by the OAR in the development of the next iteration of the NIH Research Priorities and Funding Guidance Document for fiscal years 2021 through 2025.

Strategic Planning Workshops

The AIDS Research Program (ARP) at the National Institute on Drug Abuse (NIDA) convened a group of experts on November 9 and 14, 2018 to provide individual input on research gaps and opportunities for advancement of science at the intersection of HIV/AIDS and substance use, abuse, and addiction.

See the Strategic Planning Workshop reports

NIH Priorities for HIV and HIV-Related Research

An important new guidance setting NIH HIV/AIDS research priorities and guidelines for funding has been issued, and we wish to call this Notice to the attention of the NIDA HIV/AIDS research community http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html

NIH HIV/AIDS Research Priorities, 12-11-2015 (PDF, 751KB)

Also see NIH Director, Dr. Collins Statement on NIH Efforts to Focus Research to End the AIDS Pandemic (August 12, 2015)

Research and Training Opportunities:

Research Priorities:



Mailing Address:

AIDS Research Program
National Institute on Drug Abuse
6001 Executive Blvd, MSC 9581
Bethesda, MD 20892

This page was last updated March 2019

Get this Publication

    2019 Avenir Award

    Red ribbon to represent HIV/AIDS research and a DNA molecule to represent Genetics or Epigenetics research

    The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. 


    Director Nora Volkow presenting at the AIDS 2012 conference

    New Frontiers in NIH AIDS Research at the XIX International AIDS Conference

    National HIV/AIDS Strategy